BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11337940)

  • 1. Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype.
    Ramachandran S; Fryer AA; Smith AG; Lear JT; Bowers B; Hartland AJ; Whiteside JR; Jones PW; Strange RC
    Pharmacogenetics; 2001 Apr; 11(3):247-54. PubMed ID: 11337940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype.
    Ramachandran S; Lear JT; Ramsay H; Smith AG; Bowers B; Hutchinson PE; Jones PW; Fryer AA; Strange RC
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):61-7. PubMed ID: 9950241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours.
    Ramachandran S; Hoban PR; Ichii-Jones F; Pleasants L; Ali-Osman F; Lear JT; Smith AG; Bowers B; Jones PW; Fryer AA; Strange RC
    Pharmacogenetics; 2000 Aug; 10(6):545-56. PubMed ID: 10975609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic factors determining cutaneous basal cell carcinoma phenotype.
    Ramachandran S; Fryer AA; Strange RC
    Med Pediatr Oncol; 2001 May; 36(5):559-63. PubMed ID: 11340612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender.
    Heagerty A; Smith A; English J; Lear J; Perkins W; Bowers B; Jones P; Gilford J; Alldersea J; Fryer A; Strange RC
    Br J Cancer; 1996 Jan; 73(1):44-8. PubMed ID: 8554981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual.
    Lear JT; Heagerty AH; Smith A; Bowers B; Payne CR; Smith CA; Jones PW; Gilford J; Yengi L; Alldersea J; Fryer AA; Strange RC
    Carcinogenesis; 1996 Sep; 17(9):1891-6. PubMed ID: 8824510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci.
    Clairmont A; Sies H; Ramachandran S; Lear JT; Smith AG; Bowers B; Jones PW; Fryer AA; Strange RC
    Carcinogenesis; 1999 Jul; 20(7):1235-40. PubMed ID: 10383895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma.
    Yengi L; Inskip A; Gilford J; Alldersea J; Bailey L; Smith A; Lear JT; Heagerty AH; Bowers B; Hand P; Hayes JD; Jones PW; Strange RC; Fryer AA
    Cancer Res; 1996 May; 56(9):1974-7. PubMed ID: 8616834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma.
    Lear JT; Smith AG; Heagerty AH; Bowers B; Jones PW; Gilford J; Alldersea J; Strange RC; Fryer AA
    Carcinogenesis; 1997 Aug; 18(8):1499-503. PubMed ID: 9276622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction.
    Lear JT; Smith AG; Bowers B; Heagearty AH; Jones PW; Gilford J; Alldersea J; Strange RC; Fryer AA
    J Invest Dermatol; 1997 Apr; 108(4):519-22. PubMed ID: 9077484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of gender, skin type and polymorphic genes on clinical phenotype: use of rate of increase in numbers of basal cell carcinomas as a model system.
    Ramachandran S; Fryer AA; Lovatt TJ; Smith AG; Lear JT; Jones PW; Strange RC
    Cancer Lett; 2003 Jan; 189(2):175-81. PubMed ID: 12490310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell carcinoma.
    Ramachandran S; Fryer AA; Smith AG; Lear JT; Bowers B; Griffiths CE; Jones PW; Strange RC
    Cancer; 2000 Sep; 89(5):1012-8. PubMed ID: 10964331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients.
    Lira MG; Provezza L; Malerba G; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Alaibac M; Turco A; Girolomoni G; Tessari G
    Exp Dermatol; 2006 Dec; 15(12):958-65. PubMed ID: 17083362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the naevoid basal cell carcinoma syndrome.
    R Yang X; Pfeiffer RM; Goldstein AM
    J Med Genet; 2006 Apr; 43(4):e16. PubMed ID: 16582078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 2D6 and glutathione S-transferase genotype in sudden infant death syndrome.
    Chen CL; Liu Q; Evans WE; Sander CH; Relling MV
    J Paediatr Child Health; 1997 Feb; 33(1):31-7. PubMed ID: 9069041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the glutathione s-transferase gene polymorphisms on the susceptibility to basal cell skin carcinoma.
    Leite JL; Morari EC; Granja F; Campos GM; Guilhen AC; Ward LS
    Rev Med Chil; 2007 Mar; 135(3):301-6. PubMed ID: 17505575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility and modifier genes in cutaneous basal cell carcinomas and their associations with clinical phenotype.
    Ramachandran S; Fryer AA; Lovatt T; Lear J; Smith AG; Strange RC
    J Photochem Photobiol B; 2001 Oct; 63(1-3):1-7. PubMed ID: 11684446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in glutathione S-transferase loci as a risk factor for common cancers.
    Strange RC; Lear JT; Fryer AA
    Arch Toxicol Suppl; 1998; 20():419-28. PubMed ID: 9442313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial ovarian cancer: influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression.
    Sarhanis P; Redman C; Perrett C; Brannigan K; Clayton RN; Hand P; Musgrove C; Suarez V; Jones P; Fryer AA; Farrell WE; Strange RC
    Br J Cancer; 1996 Dec; 74(11):1757-61. PubMed ID: 8956789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.